68Ga-PSMA PET/CT and PET/MRI in high-risk prostate cancer patients

被引:8
作者
Sanli, Yasemin [1 ]
Sanli, Oner [3 ]
Simsek, Duygu Has [4 ]
Subramaniam, Rathan M. [1 ,2 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Div Nucl Med, Dallas, TX USA
[2] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA
[3] Istanbul Univ, Istanbul Fac Med, Dept Urol, Istanbul, Turkey
[4] Istanbul Univ, Istanbul Fac Med, Dept Nucl Med, Istanbul, Turkey
关键词
Ga-68-PET; MRI; Ga-68-PSMA PET; CT; high-risk prostate cancer; MEMBRANE ANTIGEN-EXPRESSION; POSITRON-EMISSION-TOMOGRAPHY; ESTRO-SIOG GUIDELINES; RADICAL PROSTATECTOMY; DIAGNOSTIC-ACCURACY; EXTRACAPSULAR EXTENSION; DISEASE RECURRENCE; LYMPH-NODES; WHOLE-BODY; THERAPY;
D O I
10.1097/MNM.0000000000000888
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Treatment of high-risk prostate cancer (HRPCa) is challenging. Local staging and metastatic evaluation are important for the patient management. Recently, prostate-specific membrane antigen (PSMA)-based imaging modalities such as PSMA PET/CT and PET/MRI have received significant attention for detection of recurrent prostate cancer sites with elevated prostate-specific antigen levels, after therapy. Current evidence suggests that these imaging modalities may also have a role for the management of patients with HRPCa. In this review, we discuss PSMA-based imaging modalities in the management of patients with HRPCa.
引用
收藏
页码:871 / 880
页数:10
相关论文
共 57 条
[1]   National Comprehensive Cancer Network Practice Guidelines 2011: Need for More Accurate Recommendations for Pelvic Lymph Node Dissection in Prostate Cancer [J].
Abdollah, Firas ;
Sun, Maxine ;
Suardi, Nazareno ;
Gallina, Andrea ;
Capitanio, Umberto ;
Bianchi, Marco ;
Tutolo, Manuela ;
Passoni, Niccolo ;
Karakiewicz, Pierre I. ;
Rigatti, Patrizio ;
Montorsi, Francesco ;
Briganti, Alberto .
JOURNAL OF UROLOGY, 2012, 188 (02) :423-428
[2]   Impact of 68Ga-Prostate-Specific Membrane Antigen PET/CT on Prostate Cancer Management [J].
Afaq, Asim ;
Alahmed, Suliman ;
Chen, Shih-hsin ;
Lengana, Thabo ;
Haroon, Athar ;
Payne, Heather ;
Ahmed, Hashim ;
Punwani, Shonit ;
Sathekge, Mike ;
Bomanji, Jamshed .
JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (01) :89-92
[3]   The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer [J].
Afshar-Oromieh, Ali ;
Babich, John W. ;
Kratochwil, Clemens ;
Giesel, Frederik L. ;
Eisenhut, Michael ;
Kopka, Klaus ;
Haberkorn, Uwe .
JOURNAL OF NUCLEAR MEDICINE, 2016, 57 :79S-89S
[4]  
Ahmad AE, 2017, ONCOLOGY-NY, V31, P794
[5]   Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study [J].
Ahmed, Hashim U. ;
Bosaily, Ahmed El-Shater ;
Brown, Louise C. ;
Gabe, Rhian ;
Kaplan, Richard ;
Parmar, Mahesh K. ;
Collaco-Moraes, Yolanda ;
Ward, Katie ;
Hindley, Richard G. ;
Freeman, Alex ;
Kirkham, Alex P. ;
Oldroyd, Robert ;
Parker, Chris ;
Emberton, Mark .
LANCET, 2017, 389 (10071) :815-822
[6]   Clinical impact of 68Ga-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer with rising prostate-specific antigen after treatment with curative intent: preliminary analysis of a multidisciplinary approach [J].
Albisinni, Simone ;
Artigas, Carlos ;
Aoun, Fouad ;
Biaou, Ibrahim ;
Grosman, Julien ;
Gil, Thierry ;
Hawaux, Eric ;
Limani, Ksenija ;
Otte, Francois-Xavier ;
Peltier, Alexandre ;
Sideris, Spyridon ;
Sirtaine, Nicolas ;
Flamen, Patrick ;
van Velthoven, Roland .
BJU INTERNATIONAL, 2017, 120 (02) :197-203
[7]   68Ga-PSMA Uptake in Combined Hepatocellular Cholangiocarcinoma With Skeletal Metastases [J].
Alipour, Ramin ;
Gupta, Sandeep ;
Trethewey, Scott .
CLINICAL NUCLEAR MEDICINE, 2017, 42 (10) :E452-E453
[8]   Positron emission tomography (PET) in primary prostate cancer staging and risk assessment [J].
Bednarova, Sandra ;
Lindenberg, Maria L. ;
Vinsensia, Maria ;
Zuiani, Chiara ;
Choyke, Peter L. ;
Turkbey, Baris .
TRANSLATIONAL ANDROLOGY AND UROLOGY, 2017, 6 (03) :413-423
[9]   Prediction of prostate cancer extracapsular extension with high spatial resolution dynamic contrast-enhanced 3-T MRI [J].
Bloch, B. Nicolas ;
Genega, Elizabeth M. ;
Costa, Daniel N. ;
Pedrosa, Ivan ;
Smith, Martin P. ;
Kressel, Herbert Y. ;
Ngo, Long ;
Sanda, Martin G. ;
DeWolf, William C. ;
Rofsky, Neil M. .
EUROPEAN RADIOLOGY, 2012, 22 (10) :2201-2210
[10]   Impact of 68Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy [J].
Bluemel, Christina ;
Linke, Fraenze ;
Herrmann, Ken ;
Simunovic, Iva ;
Eiber, Matthias ;
Kestler, Christian ;
Buck, Andreas K. ;
Schirbel, Andreas ;
Bley, Thorsten A. ;
Wester, Hans-Juergen ;
Vergho, Daniel ;
Becker, Axel .
EJNMMI RESEARCH, 2016, 6